the prospect of no periods with Lybrel, the first oral contraceptive approved for CONTINUOUS use

July 2007

Women are excited about the prospect of no periods with Lybrel, the first oral contraceptive approved for CONTINUOUS use.

It contains ethinyl estradiol 20 mcg and levonorgestrel 90 mcg. Women take active pills EVERY day for a year or longer.

This means no scheduled periods...and possibly a lower incidence of PMS, headaches, and anemia.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote